Nic 12Alternative Names: Nic-12
Latest Information Update: 13 Dec 2016
At a glance
- Originator APeT
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Clinical Phase Unknown Attention-deficit hyperactivity disorder; Autistic disorder
Most Recent Events
- 13 Dec 2016 Clinical trials in Attention-deficit hyperactivity disorder in Netherlands (PO) before December 2016
- 13 Dec 2016 Clinical trials in Autistic disorder in Netherlands (PO) before December 2016